Prophylactic efficacy of probiotics on travelers’ diarrhea: an adaptive meta-analysis of randomized controlled trials
0
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
OBJECTIVES: The 2017 guideline for the prevention of travelers’ diarrhea (TD) by the International Society of Travel Medicine suggested that ‘there is insufficient evidence to recommend the use of commercially available prebiotics or probiotics to prevent or treat TD.’ However, a meta-analysis published in 2007 reported significant efficacy of probiotics in the prevention of TD (summary relative risk [sRR], 0.85, 95% confidence interval [CI], 0.79 to 0.91). This study aimed to synthesize the efficacy of probiotics on TD by updating the meta-analysis of double-blind, placebo-controlled, randomized human trials. METHODS: The search process was conducted by the adaptive meta-analysis method using the ‘cited by’ and ‘similar articles’ options provided by PubMed. The inclusion criteria were double-blind, placebo-controlled, randomized human trials with hypotheses of probiotics as intervention and TD as an outcome. The adaptive meta-analysis was conducted using Stata software using the csi, metan, metafunnel, and metabias options. RESULTS: Eleven articles were selected for the meta-analysis. The sRR was 0.85 (95% CI, 0.79 to 0.91) and showed statistical significance. There was no heterogeneity (I-squared=28.4%) and no publication bias. CONCLUSIONS: Probiotics showed statistically significant efficacy in the prevention of TD.
Abstract
OBJECTIVES: The 2017 guideline for the prevention of travelers’ diarrhea (TD) by the International Society of Travel Medicine suggested that ‘there is insufficient evidence to recommend the use of commercially available prebiotics or probiotics to prevent or treat TD.’ However, a meta-analysis published in 2007 reported significant efficacy of probiotics in the prevention of TD (summary relative risk [sRR], 0.85, 95% confidence interval [CI], 0.79 to 0.91). This study aimed to synthesize the efficacy of probiotics on TD by updating the meta-analysis of double-blind, placebo-controlled, randomized human trials. METHODS: The search process was conducted by the adaptive meta-analysis method using the ‘cited by’ and ‘similar articles’ options provided by PubMed. The inclusion criteria were double-blind, placebo-controlled, randomized human trials with hypotheses of probiotics as intervention and TD as an outcome. The adaptive meta-analysis was conducted using Stata software using the csi, metan, metafunnel, and metabias options. RESULTS: Eleven articles were selected for the meta-analysis. The sRR was 0.85 (95% CI, 0.79 to 0.91) and showed statistical significance. There was no heterogeneity (I-squared=28.4%) and no publication bias. CONCLUSIONS: Probiotics showed statistically significant efficacy in the prevention of TD.
참고문헌 (20)
- Riddle MS, "Guidelines for the prevention and treatment of travelers’ diarrhea: a graded expert panel report", J Travel Med, 24, pp.S57~S74 (2017)
- Gascón J., "Epidemiology, etiology and pathophysiology of traveler’s diarrhea", Digestion, 73(Suppl 1), pp.102~108 (2006)
- Virk A, "A randomized, double blind, placebo-controlled trial of an oral synbiotic (AKSB) for prevention of travelers’ diarrhea", J Travel Med, 20, pp.88~94 (2013)
- Sazawal S, "Efficacy of probiotics in prevention of acute diarrhoea: a meta-analysis of masked, randomised, placebo-controlled trials", Lancet Infect Dis, 6, pp.374~382 (2006)
- McFarland LV, "Meta-analysis of probiotics for the prevention of traveler’s diarrhea", Travel Med Infect Dis, 5, pp.97~105 (2007)
- de dios Pozo-Olano J, "Effect of a lactobacilli preparation on traveler’s diarrhea. A randomized, double blind clinical trial", Gastroenterology, 74, pp.829~830 (1978)
- Oksanen PJ, "Prevention of travellers’ diarrhoea by Lactobacillus GG", Ann Med, 22, pp.53~56 (1990)
- Katelaris PH, "Lactobacilli to prevent traveler’s diarrhea?", N Engl J Med, 333, pp.1360~1361 (1995)
- Hilton E, "Efficacy of Lactobacillus GG as a diarrheal preventive in travelers", J Travel Med, 4, pp.41~43 (1997)
- Black FT, "Prophylactic efficacy of Lactobacilli on traveler’s diarrhea", Travel Med, 7, pp.333~335 (1989)
- Kollaritsch H, "Prevention of traveller’s diarrhea: comparison of different non-antibiotic preparations", Travel Med Int, 6, pp.9~17 (1989)
- Kollaritsch H, "Prevention of traveler’s diarrhea with Saccharomyces boulardii. Results of a placebo controlled double-blind study", Fortschr Med, 111, pp.152~156 (1993)
- Ritchie ML, "A meta-analysis of probiotic efficacy for gastrointestinal diseases", PLoS One, 7, pp.e34938~ (2012)
- 배종면, "Citation Discovery Tools for Conducting Adaptive Meta-analyses to Update Systematic Reviews", 예방의학회지, 49(2), pp.129~133 (2016), 대한예방의학회
- 심성률, "중재 메타분석을 위한 STATA 명령어", 보건정보통계학회지, 41(1), pp.123~134 (2016), 한국보건정보통계학회[DOI]
- Briand V, "Absence of efficacy of nonviable Lactobacillus acidophilus for the prevention of traveler’s diarrhea: a randomized, double-blind, controlled study", Clin Infect Dis, 43, pp.1170~1175 (2006)
- Drakoularakou A, "A double-blind, placebo-controlled, randomized human study assessing the capacity of a novel galacto-oligosaccharide mixture in reducing travellers’ diarrhoea", Eur J Clin Nutr, 64, pp.146~152 (2010)
- Hasle G, "Can a galacto-oligosaccharide reduce the risk of traveller’s diarrhoea? A placebo-controlled, randomized, double-blind study", J Travel Med (2017)[DOI]
- Kollaritsch HH, "Prevention of traveler’s diarrhea: a double-blind randomized trial with Saccharomyces cerevisiae Hansen CBS 5926", Travel Med, 7, pp.328~332 (1989)
- Wilkins T, "Probiotics for gastrointestinal conditions: a summary of the evidence", Am Fam Physician, 96, pp.170~178 (2017)